Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
12/14/1995 | WO1995033457A1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
12/14/1995 | CA2192305A1 Conformationally constrained backbone cyclized peptide analogs |
12/14/1995 | CA2191610A1 Ligands for induction of antigen specific apoptosis in t cells |
12/14/1995 | CA2187531A1 Tachykinin (nk1) receptor antagonists |
12/13/1995 | EP0686642A2 Modified guanidino and amidino thrombin inhibitors |
12/13/1995 | EP0686154A1 Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof |
12/13/1995 | EP0513149B1 Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity |
12/12/1995 | US5475113 Tetrahydronaphthyl and thiazole, oxazole or imidazole substituted ethene derivatives having retinoid-like activity, reduced skin toxicity and reduced teratogenecity |
12/12/1995 | US5475034 Adminstering 3-benzoylphenylacetamide derivatives |
12/12/1995 | US5475018 Antiinflammatory agent, antiarthritic agent; analgesics and antipyretics |
12/12/1995 | US5475017 Diaryl-substituted heterocyclic compounds, drugs and cosmetics obtained therefrom |
12/12/1995 | US5474995 Phenyl heterocycles as cox-2 inhibitors |
12/12/1995 | US5474988 Analgesics, antiinflammatory agents |
12/12/1995 | US5474987 Methods of using low molecular weight heparins treatment of pathological processes |
12/12/1995 | US5474771 Inhibits T cell activation of B cells ; binds to epitope |
12/12/1995 | US5474759 Non-chlorofluorocarbon aerosol formulations |
12/12/1995 | CA1337717C Monoclonal antibodies against human necrosis factor (tnf) _ use thereof for detecting tnf in samples, and pharmaceutical compositions containing them |
12/11/1995 | CA2151412A1 Modified guanidino and amidino thrombin inhibitors |
12/07/1995 | WO1995032972A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
12/07/1995 | WO1995032971A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF |
12/07/1995 | WO1995032970A1 (a)-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
12/07/1995 | WO1995032948A1 Quinoline derivatives as tachykinin nk3 receptor antagonists |
12/07/1995 | WO1995032945A1 Compositions and methods for treating mast-cell mediated conditions |
12/07/1995 | WO1995032944A1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
12/07/1995 | WO1995032718A1 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease |
12/07/1995 | WO1995032715A1 Nitric oxide donor composition and method for treatment of anal disorders |
12/07/1995 | WO1995032627A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
12/07/1995 | DE4419315A1 New hetero- and oxo-pyrrolizine derivs. |
12/07/1995 | DE4419247A1 New pyrrolizine keto-acid, keto-ester and carboxamide derivs. |
12/07/1995 | DE4419246A1 New hetero-aryl substd. pyrrolizine derivs. |
12/07/1995 | CA2191745A1 [a]-annelated pyrrole derivatives and pharmaceutical uses thereof |
12/06/1995 | EP0685479A1 Heterocyclylcarbonyl substituted benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives |
12/06/1995 | EP0685476A1 Benzo(5,6)cycloheptapyridines, compositions and methods of use |
12/06/1995 | EP0685475A1 Amino-benzofuryl-and thienyl-derivatives |
12/06/1995 | EP0685474A1 Oxalylamino-benzofuran- and benzothienyl-derivatives |
12/06/1995 | EP0684953A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives |
12/06/1995 | EP0684820A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
12/06/1995 | EP0593478B1 Leukotriene b 4 antagonists |
12/06/1995 | EP0588850B1 N-hydroxyurea derivatives which inhibit lipoxygenase |
12/06/1995 | EP0544819B1 Indole derivatives which inhibit leukotriene biosynthesis |
12/06/1995 | EP0445255B1 Treatment of conditions and disease |
12/06/1995 | EP0429542B1 Leukocyte adhesion inhibitor |
12/05/1995 | US5473100 Hydroxamic acid derivative |
12/05/1995 | US5473096 Substituted benzoate derivatives |
12/05/1995 | US5473079 Process for preparing 2-arylbenzimidazole-5-sulfonic acids |
12/05/1995 | US5473071 Process for the preparation of fused pyridine compounds |
12/05/1995 | US5472982 Emulsified external treatment composition containing diclofenac sodium |
12/05/1995 | US5472964 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
12/05/1995 | US5472939 Method of treating complement mediated disorders |
12/05/1995 | CA2001194C Use of resiniferatoxin and analogues thereof to cause sensory afferent c-fiber and thermoregulatory desensitization |
12/01/1995 | CA2150305A1 Heterocyclylcarbonyl substituted benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives |
12/01/1995 | CA2150301A1 Oxalylamino-benzofuran-and benzothienyl-derivatives |
12/01/1995 | CA2150300A1 Amino-benzofuryl- and thienyl-derivatives |
11/30/1995 | WO1995032285A2 Transgenic arthritic mice |
11/30/1995 | WO1995032282A1 Interleukin-6 splice variant |
11/30/1995 | WO1995032194A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids |
11/30/1995 | WO1995031991A2 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
11/30/1995 | WO1995031987A1 Use of pteridine derivatives as no-synthase inhibitors |
11/30/1995 | WO1995031985A2 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
11/30/1995 | WO1995031984A1 Method and reagents for the treatment of rheumatoid arthritis |
11/30/1995 | WO1995031968A1 Non-steroidal anti-inflammatory ophthalmic suspensions |
11/30/1995 | DE4418096A1 Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase The use of pteridine derivatives as inhibitors of NO synthase |
11/30/1995 | CA2190468A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids |
11/30/1995 | CA2188582A1 Method and reagents for the treatment of rheumatoid arthritis |
11/29/1995 | EP0684257A1 Pseudopeptide derivatives of neurokinines, process for their preparation and pharmaceutical compositions comprising them |
11/29/1995 | EP0684241A1 N-pyridyl carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them |
11/29/1995 | EP0684240A1 Hydroxamic acid derivatives with tricyclic substitution |
11/29/1995 | EP0683781A1 Novel inhibitors of adenosine monophosphate deaminase |
11/29/1995 | EP0683767A1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists |
11/29/1995 | EP0632726A4 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability. |
11/29/1995 | EP0359783B1 Treatment of autoimmune diseases by oral administration of autoantigens |
11/28/1995 | US5470978 Process and intermediates for the preparation of excitatory amino acid receptor antagonists |
11/28/1995 | US5470885 Respriatory, gastrointestinal |
11/28/1995 | US5470882 Diphenylsulfide with urea and sulfonates |
11/28/1995 | US5470871 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives |
11/28/1995 | US5470864 Glycine amide derivatives containing pyridine or pyridine-N-oxide, anticholesterol, antiinflammatory |
11/28/1995 | US5470855 Certain heterocyclic thiazole derivatives and their therapeutic use |
11/28/1995 | US5470844 Heterocyclic-NMDA antagonists |
11/28/1995 | US5470843 Carbohydrate-containing polymers, their preparation and use |
11/28/1995 | US5470842 Carbohydrate-based anti-inflammatory agents |
11/28/1995 | US5470840 Anti-inflammatory compounds and compositions |
11/28/1995 | US5470832 Inhibitors of geranylgeranyl-protein transferase |
11/28/1995 | US5470825 Basophil granule proteins |
11/28/1995 | US5470578 Antirheumatic composition |
11/28/1995 | CA1337660C Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives |
11/28/1995 | CA1337642C Neutrophil chemotactic factor, cloned cdna and monoclonal antibodies thereto |
11/23/1995 | WO1995031566A1 Compositions and methods for targeting gene delivery vehicles |
11/23/1995 | WO1995031543A1 Dna encoding the beta subunit of a mammalian 'maxi-k' potassium channel |
11/23/1995 | WO1995031482A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
11/23/1995 | WO1995031467A1 Monocyte chemotactic protein-4 |
11/23/1995 | WO1995031463A1 New antagonist compounds |
11/23/1995 | WO1995031451A1 Novel compounds |
11/23/1995 | WO1995031206A1 P75 tnf receptor promoters |
11/23/1995 | WO1995031205A1 Sialic acid/fucose based medicaments |
11/23/1995 | WO1995031203A1 Oral liquid alendronate formulations |
11/23/1995 | WO1995031197A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
11/23/1995 | WO1995031193A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same |
11/23/1995 | DE4417865A1 Two component tumour therapy using necrosis inducing agent |
11/23/1995 | CA2190262A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
11/23/1995 | CA2189970A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same |